BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2022

Jun 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2022-06-07

Reporting Person: INGRAM ROBERT ALEXANDER (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-07	Common Stock	A	12866	—	Acquired	95004	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-07	Automatic Stock Option Grant	$10.79	A	30022	Acquired	2032-06-07	Common Stock (30022)	Direct

Footnotes

F1: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

F2: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.